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A B S T R A C T
Background: Atherosclerosis features a deterioration of the endothelial layer in all stages. Restoration of
the endothelium is associated with circulating stem cell antigen 1 (sca1) and vascular endothelial
growth factor receptor type 2 (ﬂk-1) positive endothelial progenitor cells (EPCs). We investigated
whether EPC production and/or a mobilization from bone marrow are reduced in severe atherosclerosis.
Methods and results: EPCs in peripheral blood were diminished in ApoE/ mice with high-fat diet
(HFD) whereas bone marrow levels of these cells were not signiﬁcantly altered compared to controls.
In situ perfusion of the hind limbs demonstrated that EPC mobilization was reduced compared to
ApoE/ mice with normal chow, although increased plasma stromal cell-derived factor (SDF) 1a and
responsivity suggested a mobilizing stimulus. The proliferation of sca1/ﬂk-1 positive cells showed no
functional impairment.
EPCs could not only be signiﬁcantly mobilized from the bone marrow through the application of
granulocyte colony stimulating factor (GCSF), but also led by trend to a depletion of the bone marrow
pool. GCSF levels in plasma were equal in ApoE/ mice with normal chow or HFD, which excluded a
decline in GCSF production.
Conclusion: The capability of the bone marrow pool to adapt the proliferation and mobilization of sca1/
ﬂk-1 positive EPCs seems overstrained in ApoE/ mice with a HFD.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Atherosclerosis is a chronic inﬂammatory disease, which
features an accumulation of oxidized lipids and deterioration of
the endothelial layer in all disease stages. Damaged, dysfunctional
endothelial cells (ECs) lose their capability of vasorelaxation and
express adhesion molecules, which lead to the migration of
inﬂammatory cells into the vascular wall [1]. The mismatch of
endothelial dysfunction and EC repair is pivotal for the develop-
ment of atherosclerosis. EC reconstitution is not only generated by
proliferation of neighboring ECs, but appears to be inﬂuenced by
circulating, putatively bone marrow derived endothelial stem and
progenitor cells [2]. Interestingly, various subsets of these putative* Corresponding author at: Medizinische Klinik und Poliklinik II, Sigmund-Freud-
Strasse 25, 53105 Bonn, Germany. Tel.: +490228 287 15217; fax: +49 0228 287 16423.
E-mail address: martin.steinmetz@ukb.uni-bonn.de (M. Steinmetz).
1 These authors contributed equally.
http://dx.doi.org/10.1016/j.jjcc.2015.02.008
0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsendothelial progenitors are diminished in atherosclerotic disease
and are inversely correlated to cardiovascular risk and disease
burden [3,4]. Stem cell antigen 1 (sca1) and vascular endothelial
growth factor (VEGF) receptor type 2 (ﬂk-1) double positive cells
have been considered as circulating endothelial progenitor cells
(EPCs) in the past. Previous data by others and us have correlated
decreased levels of putative EPCs in peripheral blood with
increased atherosclerotic burden and worsened endothelial
dysfunction (review see [5]). On the other hand, increased levels
of sca1/ﬂk-1 positive EPCs have been associated with improved
reendothelialization [6–8] and diminished atherosclerotic plaques
[9], suggesting a beneﬁcial effect. However, their cellular identity is
questioned in order to understand their biological role and
potential. Whereas ‘‘early’’ EPCs most frequently are monocytes
that are ‘‘contaminated’’ with thrombocyte microparticles mim-
icking endothelial features during in vitro culture [10], and
endothelial colony forming cells (ECFCs or ‘‘late EPCs’’) resemble
ECs in transcriptional proﬁling [11]. Circulating EPCs ﬁnally are reserved.
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investigated surface marker combinations comprise a heteroge-
neous composition of CD45 positive and negative cells, with
hematopoietic and endothelial potential (also see review [12]).
Predominantly circulating EPCs were successfully used as a
biomarker. Tracking their routes in the circulation from bone
marrow to peripheral blood is relevant to understand their
implication in cardiovascular diseases.
We hypothesized, that a reduction in circulating sca1/ﬂk-1
positive EPC production and/or a defect in mobilization from the
bone marrow into circulation might be associated with the
aggravation of atherosclerotic disease in apolipoprotein E-deﬁ-
cient (ApoE/) mice.
The following results illustrate that sca1/ﬂk-1 positive EPCs are
diminished in ApoE/ mice with high-fat diet (HFD), despite
mobilizing stimuli. Through the use of an in situ perfusion model
we demonstrate for the ﬁrst time with a direct approach that EPC
egress from the bone marrow into the circulation declines, and can
be transitorily restored through the application of granulocyte
colony stimulating factor (GCSF).
Materials and methods
All animal experiments were performed in accordance with
institutional guidelines and the German animal protection law.
Flow cytometry analysis of peripheral blood, bone marrow cells, and
venous perfusate
The analysis of peripheral blood, bone marrow cells, and venous
perfusate was performed by ﬂow cytometry analysis according to
previously published protocols [7]. The lymphocyte population
was analyzed for the expression of sca1-APC (R&D Systems,
Minneapolis, MN, USA) and ﬂk-1-PE (Becton Dickinson, Franklin
Lakes, NJ, USA). Isotype-identical antibodies and unstained
samples served as controls (Becton Dickinson). Cell ﬂuorescence
was measured immediately after staining using a FACSCalibur
instrument (Becton Dickinson). Data were analyzed using FlowJo
software (Tree Star, Inc., Ashland, OR, USA).
Carotid artery denudation
Carotid artery injury was induced as described previously
[7]. Brieﬂy, the common carotid artery was exposed and submitted
to an electric injury starting at the bifurcation and continuing to
the proximal part of the artery (in total 4 mm denudation). The
denuded area of the common carotid artery was determined at day
5 after surgery following intra-arterial injection of 50 ml Evans
blue in an enface preparation of the vessel. Evans blue stained
denuded areas and the complete vessel area was measured using
AxioVision version 4.5.0 software (Zeiss, Jena, Germany). The
percentage of reendothelialization 5 days after injury is provided.
In situ perfusion of mouse hind limb
The mice were anesthetized, and the femoral artery and vein of
the left hind limb were exposed. The hind limb was functionally
isolated by occlusion of the external iliac artery, superﬁcial
epigastric branch, and muscular branch (braded silk sutures 6,0,
Resorba, Nu¨rnberg, Germany). Heparinized (Heparin-Natrium
25000, Ratiopharm, Ulm, Germany) polyethylene cannulae (Fine
Science Tools, 0.2 mm, Heidelberg, Germany) were inserted into
the femoral artery and vein. Perfusion buffer (phosphate buffered
saline) was infused via the femoral artery and mobilized cells were
collected via the femoral vein using a peristaltic pump (Roller
Pump Reglo Digital, 4 Channels, Harvard Apparatus, Holliston, MA,USA). The hind limb was perfused for an initial 10 min (0.1 ml/min)
to remove remaining blood from the vasculature, and then
perfused for a further 60 min to collect mobilized cells. After
sample collection, mobilized cells were analyzed through ﬂow
cytometry as described above. To exclude mobilized cells that were
mechanically mobilized from the bone marrow, the bone marrow
of the right and left limb was analyzed separately [13–15].
For further information see Supplementary methods.
Results
Circulating sca1/ﬂk-1 positive EPCs and in vitro cultured EPCs decline
in ApoE/ with HFD
ApoE/ mice developed atherosclerotic plaques, which were
aggravated by the addition of a HFD (Fig. S1). We quantiﬁed EPC
subsets in the blood circuit and bone marrow, with low numbers of
those cells indicating an aggravation of disease [16]. As expected,
the number of sca1/ﬂk-1 positive EPCs in peripheral blood
decreased in ApoE/ with HFD compared with ApoE/
receiving normal chow, whereas bone marrow levels of sca1/ﬂk-
1 positive EPCs appeared equal between the groups (Fig. 1A).
Concordantly, the number of in vitro cultured colony forming
units-Hill and late EPC was signiﬁcantly reduced in ApoE/ mice
with HFD compared to ApoE/ with normal chow (Fig. 1B).
Low EPC levels have been previously linked to endothelial
dysfunction and the diminished capacity of endothelial recovery
[7]. Hence, we assessed the impact of HFD on endothelial
reendothelialization in ApoE/ mice after carotid artery denu-
dation. Five days after surgery, ApoE/ mice with HFD showed
signiﬁcantly reduced reendothelialization (Fig. 1C).
These results raised the question whether EPCs are reduced in
atherosclerosis only due to an augmented turnover as previously
demonstrated by Foteinos et al. [17], or if less production and
mobilization from the bone marrow compartment additionally
contribute.
Mobilization of EPCs is diminished in ApoE/ with HFD
To assess the mobilization from the bone marrow pool in vivo,
we used an in situ perfusion model to enumerate sca1/ﬂk-1
positive EPCs (Fig. 2). Since mobilized EPCs might redistribute
immediately into different compartments such as liver or spleen,
be recruited into atherosclerotic lesions or come back into the bone
marrow pool, blood sample analysis of circulating sca1/ﬂk-1
positive EPCs does not necessarily represent their mobilization
from the bone marrow but also from other niches. We used in situ
perfusion of a functionally isolated (i.e. ligated) hind limb as
modiﬁed by Pitchford and Rankin [13] to overcome these
analytical problems.
In this model, the number of sca1/ﬂk-1 positive EPCs in the
perfusate of ApoE/ with normal chow was signiﬁcantly higher
(Fig. 2A). Bone marrow levels of sca1/ﬂk-1 positive cells of the left
(perfused) and right (non-perfused) hind limb did not differ
signiﬁcantly (Fig. 2B).
SDF-1a is increased in ApoE/ mice with and without HFD
Stromal cell-derived factor 1 alpha (SDF-1a) is pivotal for stem
and progenitor homing in tissues [18]. SDF-1a/CXCR4 binding in
the bone marrow compartment is responsible for stem cell
retention. Elevated levels of circulating SDF-1a represent a strong
mobilizing stimulus [19]. We observed equal concentrations of
SDF-1a in the plasma samples of ApoE/ with normal chow or
HFD, bone marrow supernates (Fig. 3A), protein or mRNA (Fig. 3B
and C). The protein and mRNA expressions of C-X-C motif receptor
Fig. 1. EPCs and reendothelialization in ApoE/ mice. (A) ApoE/ with HFD showed signiﬁcantly decreased level of circulating sca1/ﬂk1-positive EPCs in peripheral blood.
Bone marrow levels of sca1/ﬂk-1 positive cells equaled ApoE/ with normal chow (n = 8–9). (B) Cell culture of spleen-derived mononuclear cells showed decreased
amounts of CFU-Hill, and late EPC in ApoE/ mice with HFD; circulating angiogenic cell was equal between the two groups (n = 6–11). (C) After carotid artery denudation
ApoE/ mice with HFD showed signiﬁcantly reduced reendothelialization compared to ApoE/ mice with normal chow (n = 4–5). *p < 0.05; **p < 0.01; ***p < 0.001. All
ApoE/ mice were 6 months old at the beginning of treatment. ApoE/ mice were fed normal chow (ApoE/) or high-fat diet (ApoE/ + HFD) for 7 weeks. ApoE,
apolipoprotein E; HFD, high-fat diet; EPC, endothelial progenitor cell; CFU, colony forming unit.
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and C). The comparison with plasma of younger ApoE/ mice
which were killed at the age of 3 months (without signiﬁcant
atherosclerotic plagues; data not shown) demonstrated that SDF-
1a was signiﬁcantly elevated in the older animals (Fig. 3A).
Interestingly, the addition of a HFD did not lead to a further
elevation of plasma SDF-1a, but a higher responsivity of sca1/ﬂk-1
positive EPCs migration toward SDF-1a in a modiﬁed Boyden
chamber.
These observations suggested a mobilizing stimulus for
progenitor cells in ApoE/ mice with HFD although the level
of circulating sca1/ﬂk-1 positive EPCs was signiﬁcantly reduced in
these mice.
Analyses of in vivo proliferation show no loss of function of sca1/ﬂk1
positive EPCs in ApoE/ mice
To exclude that the low level of circulating sca1/ﬂk1 positive
EPCs is related to a reproductive defect of these cells, we analyzedtheir ability for proliferation in bone marrow using a BrdU-
incorporation assay. ApoE/ mice with HFD showed a signiﬁ-
cantly increased proliferation of sca1/ﬂk-1 positive cells within the
bone marrow compared to ApoE/ with normal chow (Fig. 3C).
Concordantly telomerase activity – displaying the replicative
activity of cells – was increased in bone marrow derived cells of
ApoE/ with HFD (Fig. 3D).
GCSF treatment increases level of circulating sca1/ﬂk-1 positive EPCs
in ApoE/ mice
GCSF is able to boost the number of circulating sca1/ﬂk-1
positive EPCs in peripheral blood [20]. To unmask a failure of EPC
mobilization in ApoE/ mice with HFD, we treated the mice for 1,
3, or 5 days with GCSF, and analyzed sca1/ﬂk-1 positive EPCs with
our in situ perfusion model. Both ApoE/ mice with normal or
HFD mobilized more EPCs compared to placebo-treated mice
(Fig. 4A). Although mobilization had started already after 1 day in
ApoE/ with normal diet and peaked after 3 days of treatment,
Fig. 2. In situ perfusion model. The femoral artery and vein of the left hind limb were exposed and isolated by occlusion of the external iliac artery, superﬁcial epigastric branch
and muscular branch. After insertion of heparinized polyethylene cannulae, perfusion buffer (phosphate-buffered saline) was infused via the femoral artery and mobilized
cells were collected via the femoral vein using a peristaltic pump. (A) ApoE/ mice with HFD mobilized less sca1/ﬂk-1 positive EPCs compared to ApoE/ mice with normal
chow. (B) Comparison of the bone marrow level of sca1/ﬂk-1 positive EPCs of the perfused and non-perfused hind limb after perfusion showed no signiﬁcant differences
(n = 8–13). *p < 0.05; ns, non-signiﬁcant. All ApoE/ mice were 6 months old at the beginning of treatment. ApoE/ mice were fed normal chow (ApoE/) or high-fat diet
(ApoE/ + HFD) for 7 weeks. ApoE, apolipoprotein E; HFD, high-fat diet; EPC, endothelial progenitor cell.
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3-day treatment. In both groups, EPC mobilization declined after
5 days of treatment.
Bone marrow levels of sca1/ﬂk-1 positive EPCs declined by
trend in ApoE/ mice with normal chow or HFD, suggesting that
excessive treatment with GCSF may progressively lead to the
exhaustion of the bone marrow pool (Fig. 4B).
Eventually, both groups had similar GCSF concentrations in
plasma (Fig. 4C). In summary these data contradict a mobilizing
defect in ApoE/ mice based on a lack of GCSF.
Discussion
The association of endothelial health and circulating progenitor
cells with biomarker or even regenerative potential provides
options to positively adjust the course of atherosclerosis. In mouse
models, sca1/ﬂk-1 positive EPCs in the blood are a sensitive index
for endothelial health [16]. Grasping the mechanisms underlying
cellular replacement of the endothelial layer and their relation tobone marrow derived cells is crucial to expand our knowledge
about vascular biology in atherosclerosis. The successive failure of
repair mechanisms in chronic stages of the disease is pivotal for
any therapeutic approach. We did not address the fate or exact
function of circulating EPCs in our atherosclerotic model, but give
in situ information on their proliferation and mobilization for the
ﬁrst time. This complements available in vitro data concerning the
cellular functionality, and the analysis of cell numbers in several
compartments as surrogate parameters for mobilization.
ApoE/ mice expectedly developed signiﬁcant aortic plaques,
which were further aggravated through a HFD. The levels of not
only sca1/ﬂk-1 positive EPCs, ex vivo cultured colony forming
units-Hill – i.e. ‘‘early endothelial progenitor cells’’– but also
endothelial colony forming cells (‘‘late endothelial progenitor
cells’’) declined in the course of atherosclerosis. Circulating EPCs
and early EPCs have been previously examined in human and
murine cardiovascular diseases [3,4,16]. Data on late EPC are
scarcely available, but comply with the other subsets and are less
frequent in ApoE/ with HFD. Finally, reendothelialization was
Fig. 3. Mobilizing stimuli and proliferative activity in ApoE/ mice. (A) Expression of SDF-1a in plasma is signiﬁcantly increased with age in ApoE/ mice with normal
chow or HFD (n = 10–12) when compared to younger ApoE/ mice (n = 4–5) with the same dietary regimen. There were no differences in the supernatant of ﬂushed bone
marrow. Western blots (B) and quantitative real-time PCR (C) showed no differences of SDF-1a or its receptor CXCR4 between bone marrow samples of old ApoE/ mice
(n = 7–8). (D) The migration of sca1 positive cells and sca1/ﬂk-1 positive EPCs torwards SDF-1a in modiﬁed Boyden chambers is stronger in ApoE/ mice with HFD (n = 7–8).
(E) The proliferation of sca1/ﬂk-1 positive EPCs was quantiﬁed through the incorporation of BrdU (4 h after intraperitoneal injection), and was increased in ApoE/ mice
with HFD (n = 7–8). (F) Telomerase activity of isolated bone marrow cells was also increased in ApoE/ mice with HFD (n = 9). *p < 0.05; **p < 0.01; ***p < 0.001; ns, non-
signiﬁcant. All ApoE/ mice were 6 months old at the beginning of treatment if not otherwise indicated. ApoE/ mice were fed normal chow (ApoE/) or high-fat diet
(ApoE/ + HFD) for 7 weeks. ApoE, apolipoprotein E; SDF-1a, stromal cell-derived factor 1a; HFD, high-fat diet; EPC, endothelial progenitor cell; PCR, polymerase chain
reaction; CXCR4, C-X-C motif receptor 4.
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which conﬁrmed the worsening of endothelial health and
regeneration.
To understand the reduction of these cells in the circulation, we
took into consideration (i) an increased turnover or even
consumption of mobilized cells due to ongoing EC replacement,
(ii) a disturbance in production on bone marrow level, and (iii) a
dysfunction or reduction of progenitor cell mobilization out of the
bone marrow.
Foteinos, Xu and colleagues already demonstrated that the
endothelial turnover in ApoE/ mice with atherosclerotic lesions
is accelerated, and bone marrow derived progenitors may
immediately participate in that course of action (the latter in
transplantation experiments with LacZ+ bone marrow) [17]. This
observation was challenged by Hagensen et al., who did not see a
signiﬁcant replacement of endothelial cells through bone marrow
derived cells in carotid transplantation experiments, questioning
the hypothesis of immediate cellular replacement [21]. Despiteongoing debate on the contribution of vascular/endothelial
precursor cells either through cellular replacement, or in a
paracrine manner [22], the general involvement of ‘‘progenitor
cells’’ – with both a stem and endothelial cell identity – in vascular
disease and reconstitution is widely accepted, as is the association
of low circulating progenitor levels – such as sca1/ﬂk-1 positive
EPCs in mouse models – with worsened endothelial function and
increased atherosclerotic burden.
The senescence of the endogenous stem and progenitor cell
pool is important for the improvement or even prevention of
atherosclerosis, as demonstrated in a previous study by Rauscher
et al. [23]. The transfer of vascular progenitor cells from young
mice into old hosts was associated with improved vascular health.
However, they observed a reduced number of CD31 positive/CD45
negative cells in the bone marrow of aged ApoE/ mice, whereas
we detected sca1/ﬂk-1 positive EPCs equal in ApoE/ mice with
normal chow vs. HFD. Zhu and colleagues found no numerical
difference for CD34/ﬂk1 positive in young or old ApoE/, or lin
Fig. 4. GCSF induced mobilization of EPCs. (A) In the in situ perfusion model, GCSF treatment led to a signiﬁcant mobilization of circulating sca1/ﬂk-1 positive EPCs in ApoE/
 with normal chow or HFD, with a peak after 3 days of pretreatment, and a decline after 5 days (n = 6–12). (B) The bone marrow reservoir of sca1/ﬂk-1 positive EPCs seemed
to be exhausted by trend (n = 7–14). (C) Plasma GCSF was similar in both ApoE/ mice with normal chow or HFD (n = 6–10). ns, non-signiﬁcant; nd, not detectable. All
ApoE/ mice were 6 months old at the beginning of treatment if not otherwise indicated. ApoE/ mice were fed normal chow (ApoE/) or high-fat diet (ApoE/ + HFD)
for 7 weeks. ApoE, apolipoprotein E; GCSF, granulocyte colony stimulating factor; EPC, endothelial progenitor cell; HFD, high-fat diet.
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linneg/sca1neg/ckitpos cell type, namely simple little cells (SLC),
which were decreased in the bone marrow of both very old
wildtype and 6-month-old ApoE/ mice [24]. We analyzed
proliferation through enumeration of sca1/ﬂk-1/BrdU-positive
cells in vivo, and found an increase of this cellular fraction in
the ApoE/ mice with HFD and aggravated disease, which
pointed to the sustained potential of EPCs to enhance and thereby
adapt cellular replication to the occurring injuries in our study.
Telomerase activity, which displays the proliferative state of cells
[25], was also drastically increased in bone marrow cells from
ApoE/ mice with HFD compared with normal chow. The bone
marrow composition and functionality seem to change in terms of
other cellular subsets, but sca1/ﬂk-1 positive EPCs preserve at least
partially their potential to replicate and reconstitute the bone
marrow pool.
Atherosclerosis in ApoE/ mice generated a strong elevation
of plasmatic SDF-1a, which implied a stimulus for mobilization.
Plasma SDF-1a elevation is reportedly necessary for cell mobili-
zation and replacement in injured organs after damage such as
myocardial infarction [26]. CXCR4 is the receptor for SDF-1a and is
expressed on various stem and progenitor cells. SDF1–CXCR4
binding causes anchorage in the bone marrow and homing in
lesion sites [27,28]. The increase in peripheral SDF-1a provokes
the egression of e.g. stem and progenitor cells from the bone
marrow into circulation [29]. Our SDF-1a measurements sug-
gested the enhanced mobilization of progenitor cells even in
ApoE/ mice with HFD, which contradicted the signiﬁcant
decrease of sca1/ﬂk-1 positive EPCs and in vitro cultured EPCs in
peripheral blood in these mice. We found no relative upregulation
of CXCR4 in the bone marrow of ApoE/ mice with HFD
compared to their littermates with standard chow, which excludes
an increased anchorage in the stem cell niches to be responsible for
the lower number of EPCs in the peripheral circulation of these
animals.
Methods to assess mobilization are still rare, and such data are
derived from either comparison of blood to bone marrow levels or
cell transplantation. In our study, we used an in situ perfusion
model, which has been established by Rankin for various animal
species, including rodents, and is described to provide a more
precise view on cell egress from the bone marrow into hind limb
vasculature. Despite its still artiﬁcial approach through the use of
limited local ischemia, the simulation of circulatory pulsation and
buffers as blood replacement, this approach is able to preciselyillustrate quantitative and qualitative differences of mobilization
in situ [13,30,31]. From this model, we yielded data of sca1/ﬂk-1
positive EPC mobilization. ApoE/ mice with a normal diet
mobilized more cells than ApoE/ mice with HFD. Stimulation
with recombinant GCSF increased this mobilization for the distinct
time period of about 3 days. Of note, GCSF is able to increase
circulating stem and progenitor cells for about 5 days in
completely healthy volunteers. Hereafter cell levels begin to
normalize and the GCSF effect fades [20]. Interestingly, ApoE/
mice with HFD lacked (unlike ApoE/ mice with normal chow)
mobilization after GCSF treatment for only one day, but had a peak
after 3 days like ApoE/ mice with standard chow. One might
speculate that mobilization is delayed, however ApoE/ mice
with HFD seemingly have no functional deﬁcit to mobilize EPCs
from the bone marrow. In contrast, excessive GCSF treatment was
associated with a non-signiﬁcant reduction of the bone marrow
pool after ﬁve days of treatment. Thus, the margin of mobilization
in atherosclerosis appears limited.
At last, plasma levels of GCSF were similar between ApoE/
mice with HFD or normal chow, so that the low mobilization of
EPCs appeared not to be related to a general deﬁciency of GCSF.
Although our data favor the overexertion of cellular reproduc-
tion for sca1/ﬂk-1 positive cells in the bone marrow, insufﬁcient
mobilization because of bone marrow dysfunction as described by
Oikawa and co-authors [32] must be mentioned. They found
rareﬁcation of medullary vessels, fatty streaks and fewer sca1/ckit
positive cells on the bone marrow of type I diabetic mice. The ﬂow
in microvessels – assessed through microspheres – was signiﬁ-
cantly reduced. Thus, mobilization from the bone marrow appears
different depending on the model of disease.
Mobilization of sca1/ﬂk-1 positive EPCs is reduced, whereas
their proliferation is enhanced and the total amount of these cells
is not signiﬁcantly altered in the bone marrow of ApoE/ mice
with HFD vs. normal chow. The severity of atherosclerotic disease
and increased turnover of progenitor cells most likely exceeds
the capability of the bone marrow to adequately increase cell
production and mobilization, and overcome EPC reduction in the
peripheral circulation. These data explain the observations of
EPCs as a biomarker, which have associated lower EPC levels with
aggravated disease. Moreover, our data suggest that the potential
of EPCs as a therapeutic tool in atherosclerosis might be limited
to earlier stages, because the endogenous cell pool might be
exhausted and not efﬁciently mobilized in more severe diseases
anymore.
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